Exploring Accelerated Growth Potential in the Alzheimer's Disease Market from 2023 to 2032: A DelveInsight Analysis Covering Sanofi, Novartis, BioVie, AB Science, Eli Lilly, Cassava Science and others

MLA

“Exploring Accelerated Growth Potential in the Alzheimer’s Disease Market from 2023 to 2032: A DelveInsight Analysis Covering Sanofi, Novartis, BioVie, AB Science, Eli Lilly, Cassava Science and Others.” M2 Presswire, 23 Nov. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.773876137&authtype=sso&custid=ns315887.

APA

Exploring Accelerated Growth Potential in the Alzheimer’s Disease Market from 2023 to 2032: A DelveInsight Analysis Covering Sanofi, Novartis, BioVie, AB Science, Eli Lilly, Cassava Science and others. (2023, November 23). M2 Presswire.

Chicago

M2 Presswire. 2023. “Exploring Accelerated Growth Potential in the Alzheimer’s Disease Market from 2023 to 2032: A DelveInsight Analysis Covering Sanofi, Novartis, BioVie, AB Science, Eli Lilly, Cassava Science and Others,” November 23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.773876137&authtype=sso&custid=ns315887.